The Board of Syngene International Limited has at its meeting held today announced the separation in roles of the Managing Director and Chairperson with effect from April 01, 2020. Accordingly, Mr. Jonathan Hunt, currently Whole-time Director and Chief Executive Officer, will assume the position of Managing Director and Chief Executive Officer of the Company and Ms. Kiran Mazumdar Shaw will become the Non-Executive Chairperson with effect from 1st April 2020.
Kiran Mazumdar Shaw, Managing Director, said "Over the past four years, under the leadership of Jonathan Hunt, Syngene has shown considerable growth while expanding its capabilities into new, emerging areas of research and development to meet the existing and future requirements of its clients. His track record demonstrates that he brings strong leadership, an ability to build sustainable partnerships with customers and a clear vision which will drive the Company's next growth phase."
Jonathan Hunt, Chief Executive Officer commented "It is an honour to be appointed as Managing Director and Chief Executive Officer of Syngene. The company is at the cusp of its next growth phase and I firmly believe that we have the right mix of scientific talent and world class technology, underpinned by a track record of quality and regulatory compliance, to achieve our ambitions. We are continuing to see increasing interest in outsourcing research and development among our customers. Against this backdrop, I believe the opportunities for Syngene are many and I am very pleased to be at the helm for the next phase."
Shares of Syngene International Ltd was last trading in BSE at Rs.312 as compared to the previous close of Rs. 306.65. The total number of shares traded during the day was 6481 in over 834 trades.
The stock hit an intraday high of Rs. 318 and intraday low of 307.1. The net turnover during the day was Rs. 2016851.